Acute lymphoblastic leukemia in adolescents and young adults Journal Article


Authors: Burke, P. W.; Douer, D.
Article Title: Acute lymphoblastic leukemia in adolescents and young adults
Abstract: The cure rate of acute lymphoblastic leukemia (ALL) in children is 80%, compared to less than half in adults. A major proportion of this cure rate drop occurs in adolescents and young adults (AYAs). The age range defining this population varies between studies, biological characteristics are different from both younger children and older adults, and AYAs are treated either by pediatric or adult oncologists, who often apply different treatment approaches to the same ALL patient population. The outcome of AYAs aged 15-21 years treated by more contemporary pediatric protocols is similar to that of younger children but is inferior when using adult regimens. This motivated studying AYA patients, including those above the age of 21 years, with pediatric or 'pediatrics-inspired' regimens that intensified nonmyelosuppressive drugs such as vincristine, steroids and asparaginase, with very promising preliminary results. Discovering new mutations in AYA ALL will help stratify patients into risk subgroups and identify targets for novel agents. This, together with fine-tuning pediatric chemotherapy principles will hopefully finally decrease the cure rate gap between children and AYAs - and even older adults. © 2014 S. Karger AG, Basel.
Keywords: survival rate; review; clinical trials as topic; antineoplastic agent; protein kinase inhibitor; antineoplastic combined chemotherapy protocols; age factors; acute lymphoblastic leukemia; age; monoclonal antibody; protein kinase inhibitors; antibodies, monoclonal; precursor cell lymphoblastic leukemia-lymphoma; biological therapy; philadelphia 1 chromosome; clinical trial (topic); philadelphia chromosome; humans; human; cell- and tissue-based therapy
Journal Title: Acta Haematologica
Volume: 132
Issue: 3-4
ISSN: 0001-5792
Publisher: S. Karger AG  
Date Published: 2014-09-01
Start Page: 264
End Page: 273
Language: English
DOI: 10.1159/000360204
PUBMED: 25228551
PROVIDER: scopus
DOI/URL:
Notes: Export Date: 1 December 2014 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dan Douer
    87 Douer
  2. Patrick William Burke
    8 Burke